These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 31661053)
1. A survey of Cochrane K; Robinson AV; Holt RA; Allen-Vercoe E Microb Genom; 2020 Feb; 6(2):. PubMed ID: 31661053 [TBL] [Abstract][Full Text] [Related]
2. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum. Despins CA; Brown SD; Robinson AV; Mungall AJ; Allen-Vercoe E; Holt RA mBio; 2021 Oct; 12(5):e0206221. PubMed ID: 34700376 [TBL] [Abstract][Full Text] [Related]
3. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions. Kumar A; Thotakura PL; Tiwary BK; Krishna R BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600 [TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner. Udayasuryan B; Zhou Z; Ahmad RN; Sobol P; Deng C; Nguyen TTD; Kodikalla S; Morrison R; Goswami I; Slade DJ; Verbridge SS; Lu C Commun Biol; 2024 May; 7(1):551. PubMed ID: 38720110 [TBL] [Abstract][Full Text] [Related]
5. Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins. Zanzoni A; Spinelli L; Braham S; Brun C Microbiome; 2017 Aug; 5(1):89. PubMed ID: 28793925 [TBL] [Abstract][Full Text] [Related]
6. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607 [TBL] [Abstract][Full Text] [Related]
7. Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840 [TBL] [Abstract][Full Text] [Related]
8. Proteomics of Fusobacterium nucleatum within a model developing oral microbial community. Hendrickson EL; Wang T; Beck DA; Dickinson BC; Wright CJ; J Lamont R; Hackett M Microbiologyopen; 2014 Oct; 3(5):729-51. PubMed ID: 25155235 [TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis of Fusobacterium nucleatum reveals differential gene expression patterns in the biofilm versus planktonic cells. Zhao T; Chen J; Liu S; Yang J; Wu J; Miao L; Sun W Biochem Biophys Res Commun; 2022 Feb; 593():151-157. PubMed ID: 35085920 [TBL] [Abstract][Full Text] [Related]
10. New Roles for Fusobacterium nucleatum in Cancer: Target the Bacteria, Host, or Both? Slade DJ Trends Cancer; 2021 Mar; 7(3):185-187. PubMed ID: 33309240 [TBL] [Abstract][Full Text] [Related]
11. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis. Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323 [TBL] [Abstract][Full Text] [Related]
13. Quantitative Proteomic Analysis of Outer Membrane Vesicles from Fusobacterium nucleatum Cultivated in the Mimic Cancer Environment. Zhang X; Wang Y; Fan R; Zhang L; Li Z; Zhang Y; Zheng W; Wang L; Liu B; Quan C Microbiol Spectr; 2023 Aug; 11(4):e0039423. PubMed ID: 37341631 [TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571 [TBL] [Abstract][Full Text] [Related]
15. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Fardini Y; Wang X; Témoin S; Nithianantham S; Lee D; Shoham M; Han YW Mol Microbiol; 2011 Dec; 82(6):1468-80. PubMed ID: 22040113 [TBL] [Abstract][Full Text] [Related]
16. Genetic Manipulation and Virulence Assessment of Fusobacterium nucleatum. Peluso EA; Scheible M; Ton-That H; Wu C Curr Protoc Microbiol; 2020 Jun; 57(1):e104. PubMed ID: 32539234 [TBL] [Abstract][Full Text] [Related]
17. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection. Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893 [TBL] [Abstract][Full Text] [Related]
18. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum. Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002 [TBL] [Abstract][Full Text] [Related]
19. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model. Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis. Lu X; Xu Q; Tong Y; Zhang Z; Dun G; Feng Y; Tang J; Han D; Mao Y; Deng L; He X; Li Q; Xiang Y; Wang F; Zeng D; Tang B; Mao X Cell Rep; 2022 Jul; 40(3):111127. PubMed ID: 35858553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]